Influvac: Difference between revisions
Content deleted Content added
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{flu}} |
{{flu}} |
||
'''Influvac''' is a sub-unit vaccine produced and marketed by [[Abbott (company)|Abbott]]. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus ([[A/H1N1]], [[A/H3N2]], and [[Influenza B]] Virus) that are selected and distributed by the [[World Health Organization]], on the basis of their latest recommendations.<ref>[http://www.solvay-influenza.com Solvay]</ref><ref name="Giezeman">K.M. Giezeman, et.al, Trivalent inactivated subunit influenza vaccine Influvac:25-Year experience of safety and immunogenicity, Elservier Journal: Vaccine(2009); 2414-17</ref> |
'''Influvac''' is a sub-unit vaccine produced and marketed by [[Abbott Laboratories(company)|Abbott Laboratories]]. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus ([[A/H1N1]], [[A/H3N2]], and [[Influenza B]] Virus) that are selected and distributed by the [[World Health Organization]], on the basis of their latest recommendations.<ref>[http://www.solvay-influenza.com Solvay]</ref><ref name="Giezeman">K.M. Giezeman, et.al, Trivalent inactivated subunit influenza vaccine Influvac:25-Year experience of safety and immunogenicity, Elservier Journal: Vaccine(2009); 2414-17</ref> |
||
The sub-unit influenza vaccine Influvac has been on the market since the early nineteen-eighties.<ref name="Giezeman" /> |
The sub-unit influenza vaccine Influvac has been on the market since the early nineteen-eighties.<ref name="Giezeman" /> |
||
Revision as of 13:05, 5 November 2011
| Influenza (flu) |
|---|
 |
Influvac is a sub-unit vaccine produced and marketed by Abbott Laboratories. It contains inactivated purified surface fragments (sub-units) from the three different strains of the influenza virus (A/H1N1, A/H3N2, and Influenza B Virus) that are selected and distributed by the World Health Organization, on the basis of their latest recommendations.[1][2]
The sub-unit influenza vaccine Influvac has been on the market since the early nineteen-eighties.[2]
References
 | This immunology article is a stub. You can help Wikipedia by expanding it. |
 | This infectious disease article is a stub. You can help Wikipedia by expanding it. |